Guodong Tie to Neovascularization, Physiologic
This is a "connection" page, showing publications Guodong Tie has written about Neovascularization, Physiologic.
Connection Strength
0.187
-
Yan J, Tie G, Wang S, Messina KE, DiDato S, Guo S, Messina LM. Type 2 diabetes restricts multipotency of mesenchymal stem cells and impairs their capacity to augment postischemic neovascularization in db/db mice. J Am Heart Assoc. 2012 Dec; 1(6):e002238.
Score: 0.091
-
Yan J, Tie G, Park B, Yan Y, Nowicki PT, Messina LM. Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells. J Vasc Surg. 2009 Dec; 50(6):1412-22.
Score: 0.073
-
Yan J, Tie G, Xu TY, Cecchini K, Messina LM. Mesenchymal stem cells as a treatment for peripheral arterial disease: current status and potential impact of type II diabetes on their therapeutic efficacy. Stem Cell Rev Rep. 2013 Jun; 9(3):360-72.
Score: 0.023